[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxyphosphonic acid(14075-00-4)
- Name: [3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxyphosphonic acid
- Synonyms:Ribofuranose,1-(dihydrogen phosphate), D- (8CI); Ribofuranose, 1-phosphate (6CI); D-Ribose1-phosphate; Ribose 1-phosphate
- Molecular Formula:C5H11 O8 P
- Molecular Weight:230.111
- CAS Registry Number:14075-00-4
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.14075-00-4 伪-D-ribose 1-phosphate
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.14075-00-4 [3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxyphosphonic acid
Assay:99% Application:Fine chemical intermediates, used as the main raw material for the synthesis of various pesticides, medicines, surfactants, polymer monomers, and antifungal agents
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.14075-00-4 [3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxyphosphonic acid
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxyphosphonic acid
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.14075-00-4 [3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl] dihydrogen phosphate
Assay:97% Appearance:white to yellow crystal powder Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 96742-98-2/7H-Dibenzo[c,g]fluorene,7,7'-[2-(7H-dibenzo[c,- g]fluoren-7-ylidenemethyl)-1,3- propanediylidene]bis-,ion(1-)
- 100237-68-1/N-(2,2-dimethylpropyl)-4-phenylphthalazin-1-amine
- 105674-77-9/Lanproston
- 173908-58-2/ethyl 1-{[5-chloro-2-(propanoylamino)phenyl]sulfonyl}-1H-pyrrole-2-carboxylate
- 149183-66-4/squasapogenol
- 29790-16-7/2,18-Diethyl-1,19,22,24-tetrahydro-3,7,13,17-tetramethyl-1,19-dioxo-21H-biline-8,12-dipropionic acid
- 9042-06-2/peptidoglycan synthetase
- 67465-87-6/1-(2,3-dihydro-1H-inden-4-yloxy)-3-[methyl(1-methyl-2-phenylethyl)amino]propan-2-ol
- 68083-97-6/2-[[4-[(6-Methoxybenzothiazol-2-yl)azo]phenyl]methylamino]ethanol
- 20595-45-3/TRANS-2,4-DICHLOROCINNAMIC ACID
- 73544-88-4/N-(3-chloro-2-methylphenyl)-2-hydroxy-3-nitrobenzamide
- 56883-86-4/1-{3-[1-(acetylamino)-2-hydroxyethyl]-3-deoxypentofuranosyl}pyrimidine-2,4(1H,3H)-dione
- 71329-18-5/Spiro[androstane-17,2'-oxazolidine]
- 33327-07-0/N-hydroxy-3-(hydroxyamino)-3-phenylpropanamide - hydroxylamine (1:1)
- 164083-84-5/[3-[[3-(2-Amino-2-oxoethyl)-2-ethyl-1-(phenylmethyl)-1H-indol-5-yl]oxy]propyl]-phosphonicacid
- 5723-93-3/3,5-di-tert-butylbiphenyl
- 67567-14-0/(2S)-2β-(3-Furyl)-5,6,6aβ,7,10,11,11aα,11b-octahydro-6α-hydroxy-11bβ-methyl-7β,10β-methano-2H-pyrano[4,3-g][3]benzoxepine-4,8(1H,4aαH)-dione
- 384-22-5/2-Nitrobenzotrifluoride
- 17829-05-9/N-NITROSODIMETHYL-D6-AMINE
- 14075-00-4/[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxyphosphonic acid
- 36441-79-9/1H-Naphth[2,1-e]indole,hexadecahydro-9a,- 11a-dimethyl-,(3aS,3bR,9aS,9bS,11aS)-
- 65168-06-1/Cuprate(1-), (29H,31H-phthalocyanine-C-sulfonato(3-)-kappaN29,kappaN30,kappaN31,kappaN32)-, aluminum (3:1)
- 64521-21-7/Nonanedioic acid, polymer with (chloromethyl)oxirane, 1,3-dihydro-1,3-dioxo-5-isobenzofurancarboxylic acid and 4,4-(1-methylethylidene)bis(phenol), compd. with 2-(dimethylamino)ethanol
- 31690-01-4/4H-[1,3]Dioxolo[4,5-h]oxireno[3,3a]indolo[7a,1-a][2]benzazepine,1a,2,5,6,12,13-hexahydro-13-methoxy-, (11bR,13R)-[partial]- (9CI)
- 15262-96-1/1-(3-chloropropyl)-3-(4-methylphenyl)-1-nitrosourea
- 13463-42-8/trihydrogen bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulphonato(3-)]chromate(3-)
- 75662-22-5/2-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yloxy)ethyl 2-methylprop-2-enoate
- 634-64-0/Tartaramic acid
- 54405-20-8/Poly(oxy-1,2-ethanediyl), .alpha.-(3-methylbutyl)-.omega.-hydroxy-
- 36524-75-1/3-[4-(3,3,3-triphenylpropyl)piperazin-1-yl]pyrazin-2-amine methanesulfonate (1:2)